Eble JN, Sauter G., Epstein JI, Sesterhenn IA - iarc

1880. Nelson RS, Epstein JI (1996).
Prostatic carcinoma with abundant xanthomatous
cytoplasm. Foamy gland carcinoma.
Am J Surg Pathol 20: 419-426.
1881. Neuhauser TS, Lancaster K, Haws R,
Drehner D, Gulley ML, Lichy JH,
Taubenberger JK (1997). Rapidly progressive
T cell lymphoma presenting as acute
renal failure: case report and review of the
literature. Pediatr Pathol Lab Med 17: 449-
460.
1882. Neumann HP, Bender BU (1998).
Genotype-phenotype correlations in von
Hippel-Lindau disease. J Intern Med 243:
541-545.
1883. Neumann HP, Wiestler OD (1994). Von
Hippel-Lindau disease: a syndrome providing
insights into growth control and tumorigenesis.
Nephrol Dial Transplant 9: 1832-
1833.
1884. Newman DM, Brown JR, Jay AC,
Pontius EE (1968). Squamous cell carcinoma
of the bladder. J Urol 100: 470-473.
1885. Newman JS, Bree RL, Rubin JM
(1995). Prostate cancer: diagnosis with
color Doppler sonography with histologic
correlation of each biopsy site. Radiology
195: 86-90.
1886. Newman PL, Fletcher CD (1991).
Smooth muscle tumours of the external
genitalia: clinicopathological analysis of a
series. Histopathology 18: 523-529.
1887. Newton WAJr, Soule EH, Hamoudi
AB, Reiman HM, Shimada H, Beltangady
M, Maurer H (1988). Histopathology of
childhood sarcomas, Intergroup
Rhabdomyosarcoma Studies I and II: clinicopathologic
correlation. J Clin Oncol 6:
67-75.
1888. Ng WK, Cheung MF, Ip P, Chan KW
(1999). Test and teach. Number ninety-two:
Part 1. Papillary renal cell carcinoma, solid
variant. Pathology 31: 213-214.
1889. Ng WT, Wong MK, Chan YT (1992).
Re: Cavernous haemangioma of the glans
penis. Br J Urol 70: 340.
1890. Nguyen PL, Swanson PE, Jaszcz W,
Aeppli DM, Zhang G, Singleton TP, Ward S,
Dykoski D, Harvey J, Niehans GA (1994).
Expression of epidermal growth factor
receptor in invasive transitional cell carcinoma
of the urinary bladder. A multivariate
survival analysis. Am J Clin Pathol 101: 166-
176.
1891. Nickerson M, Warren M, Toro J,
Matrosova V, Glenn G, Turner M, Duray P,
Merino M, Choyke P, Pavlovich C, Sharma
N, Walther M, Munroe D, Hill R, Maher E,
Greenberg C, Lerman M, Linehan W, Zbar
B, Schmidt L (2002). Mutations in a novel
gene lead to kidney tumors, lung wall
defects, and benign tumors of the hair follicle
in patients with the Birt-Hogg-Dube
syndrome. Cancer Cell 2: 157-164.
1892. Nicol D, Hii SI, Walsh M, Teh B,
Thompson L, Kennett C, Gotley D (1997).
Vascular endothelial growth factor expression
is increased in renal cell carcinoma. J
Urol 157: 1482-1486.
1893. Nicolaisen GS, Williams RD (1984).
Primary transitional cell carcinoma of
prostate. Urology 24: 544-549.
1894. Niehans GA, Manivel JC, Copland GT,
Scheithauer BW, Wick MR (1988).
Immunohistochemistry of germ cell and
trophoblastic neoplasms. Cancer 62: 1113-
1123.
1895. Nielsen H, Nielsen M, Skakkebaek NE
(1974). The fine structure of possible carcinoma-in-situ
in the seminiferous tubules in
the testis of four infertile men. Acta Pathol
Microbiol Scand [A] 82: 235-248.
1896. Nieto N, Torres-Valdivieso MJ, Aguado
P, Mateos ME, Lopez-Perez J, Melero C,
Vivanco JL, Gomez A (2002). Juvenile granulosa
cell tumor of the testis: case report and
review of literature. Tumori 88: 72-74.
1897. Nikzas D, Champion AE, Fox M (1990).
Germ cell tumours of testis: prognostic factors
and results. Eur Urol 18: 242-247.
1898. Nishiyama H, Gill JH, Pitt E, Kennedy W,
Knowles MA (2001). Negative regulation of
G(1)/S transition by the candidate bladder
tumour suppressor gene DBCCR1. Oncogene
20: 2956-2964.
1899. Nishiyama T, Ikarashi T, Terunuma M,
Ishizaki S (2001). Osteogenic sarcoma of the
prostate. Int J Urol 8: 199-201.
1900. Nistal M, Codesal J, Paniagua R (1989).
Carcinoma in situ of the testis in infertile men.
A histological, immunocytochemical, and
cytophotometric study of DNA content. J
Pathol 159: 205-210.
1901. Nistal M, Lazaro R, Garcia J, Paniagua R
(1992). Testicular granulosa cell tumor of the
adult type. Arch Pathol Lab Med 116: 284-287.
1902. Nistal M, Martinez-Garcia C, Paniagua R
(1992). Testicular fibroma. J Urol 147: 1617-1619.
1903. Nistal M, Paniagua R (1985). Primary neuroectodermal
tumour of the testis.
Histopathology 9: 1351-1359.
1904. Nistal M, Puras A, Perna C, Guarch R,
Paniagua R (1996). Fusocellular gonadal stromal
tumour of the testis with epithelial and
myoid differentiation. Histopathology 29: 259-
264.
1905. Nistal M, Redondo E, Paniagua R (1988).
Juvenile granulosa cell tumor of the testis.
Arch Pathol Lab Med 112: 1129-1132.
1906. Nistal M, Revestido R, Paniagua R (1992).
Bilateral mucinous cystadenocarcinoma of the
testis and epididymis. Arch Pathol Lab Med
116: 1360-1363.
1907. Nixon RG, Chang SS, Lafleur BJ, Smith
JA, Cookson MS (2002). Carcinoma in situ and
tumor multifocality predict the risk of prostatic
urethral involvement at radical cystectomy in
men with transitional cell carcinoma of the
bladder. J Urol 167: 502-505.
1908. Nochomovitz LE, Orenstein JO (1994).
Adenocarcinoma of the rete testis.
Consolidation and analysis of 31 reported
cases, with review of miscellaneous entities. J
Urol Pathol 2: 1-37.
1909. Nocks BN, Dann JA (1983). Primitive neuroectodermal
tumor (immature teratoma) of
testis. Urology 22: 543-544.
1910. Nocks BN, Heney NM, Daly JJ, Perrone
TA, Griffin PP, Prout GRJr (1982). Transitional
cell carcinoma of renal pelvis. Urology 19: 472-
477.
1911. Nogales FFJr, Matilla A, Ortega I, Alvarez
T (1979). Mixed Brenner and adenomatoid
tumor of the testis: an ultrastructural study and
histogenetic considerations. Cancer 43: 539-
543.
1912. Noguchi M, Hirabayashi Y, Kato S, Noda
S (2002). Solitary fibrous tumor arising from the
prostatic capsule. J Urol 168: 1490-1491.
1913. Noguchi M, Yahara J, Koga H,
Nakashima O, Noda S (1999). Necessity of
repeat biopsies in men for suspected prostate
cancer. Int J Urol 6: 7-12.
1914. Nonomura N, Miki T, Nishimura K, Kanno
N, Kojima Y, Okuyama A (1997). Altered imprinting
of the H19 and insulin-like growth factor II
genes in testicular tumors. J Urol 157: 1977-
1979.
1915. Noordzij MA, van der Kwast TH, van
Steenbrugge GJ, Hop WJ, Schroder FH (1995).
The prognostic influence of neuroendocrine
cells in prostate cancer: results of a long-term
follow-up study with patients treated by radical
prostatectomy. Int J Cancer 62: 252-258.
1916. Norden DA, Gelfand M (1972).
Bilharzia and bladder cancer. An investigation
of urinary -glucuronidase associated
with S. haematobium infection. Trans R
Soc Trop Med Hyg 66: 864-866.
1917. Norgaard-Pedersen B, Schultz HP,
Arends J, Brincker H, Krag Jacobsen G,
Lindelov B, Rorth M, Svennekjaer IL
(1984). Tumour markers in testicular germ
cell tumours. Five-year experience from
the DATECA Study 1976-1980. Acta Radiol
Oncol 23: 287-294.
1918. Norming U, Tribukait B, Gustafson H,
Nyman CR, Wang NN, Wijkstrom H (1992).
Deoxyribonucleic acid profile and tumor
progression in primary carcinoma in situ
of the bladder: a study of 63 patients with
grade 3 lesions. J Urol 147: 11-15.
1919. Norton KI, Godine LB, Lempert C
(1997). Leiomyosarcoma of the kidney in
an HIV-infected child. Pediatr Radiol 27:
557-558.
1920. Nouri AM, Darakhshan F, Cannell H,
Paris AM, Oliver RT (1996). The relevance
of p53 mutation in urological malignancies:
possible clinical implications for
bladder cancer. Br J Urol 78: 337-344.
1921. Nouri AM, Thompson C, Cannell H,
Symes M, Purkiss S, Amirghofran Z (2000).
Profile of epidermal growth factor receptor
(EGFr) expression in human malignancies:
effects of exposure to EGF and its
biological influence on established human
tumour cell lines. Int J Mol Med 6: 495-
500.
1922. Novella G, Porcaro AB, Righetti R,
Cavalleri S, Beltrami P, Ficarra V, Brunelli
M, Martignoni G, Malossini G, Tallarigo C
(2001). Primary lymphoma of the epididymis:
case report and review of the literature.
Urol Int 67: 97-99.
1923. Novis DA, Zarbo RJ, Valenstein PA
(1999). Diagnostic uncertainty expressed
in prostate needle biopsies. A College of
American Pathologists Q-probes Study of
15,753 prostate needle biopsies in 332
institutions. Arch Pathol Lab Med 123:
687-692.
1924. Nupponen NN, Kakkola L, Koivisto P,
Visakorpi T (1998). Genetic alterations in
hormone-refractory recurrent prostate
carcinomas. Am J Pathol 153: 141-148.
1925. O’Brien A, Sinnott B, McLean P,
Doyle GD (1992). Leiomyoma of the renal
pelvis. Br J Urol 70: 331-332.
1926. O’dowd GJ, Miller MC, Orozco R,
Veltri RW (2000). Analysis of repeated
biopsy results within 1 year after a noncancer
diagnosis. Urology 55: 553-559.
1927. O’Hara SM, Veltri RW, Skirpstunas
P, Hedican SP, Partin AW, Nelson JB,
Subong EN, Walsh PC (1996). Basal PSA
mRNA levels detected by quantitative
reverse transcriptase polymerase chain
reaction (Q-RT-PCR-PSA) in blood from
subjects without prostate cancer. J Urol
155: 418A.
1928. O’Kane HO, Megaw JM (1968).
Carcinoma in the exstrophic bladder. Br J
Surg 55: 631-635.
1929. O’Shaughnessy JA, Kelloff GJ,
Gordon GB, Dannenberg AJ, Hong WK,
Fabian CJ, Sigman CC, Bertagnolli MM,
Stratton SP, Lam S, Nelson WG,
Meyskens FL, Alberts DS, Follen M, Rustgi
AK, Papadimitrakopoulou V, Scardino PT,
Gazdar AF, Wattenberg LW, Sporn MB,
Sakr WA, Lippman SM, Von Hoff DD
(2002). Treatment and prevention of
intraepithelial neoplasia: an important target
for accelerated new agent development.
Clin Cancer Res 8: 314-346.
1930. Obermann EC, Junker K, Stoehr R,
Dietmaier W, Zaak D, Schubert GE,
Hofstaedter F, Knuechel R, Hartmann A
(2003). Frequent genetic alterations in flat
urothelial hyperplasias and concomitant
papillary bladder cancer as detected by
CGH, LOH, and FISH analyses. J Pathol 199:
50-57.
1931. Oberstrass J, Reifenberger G,
Reifenberger J, Wechsler W, Collins VP
(1996). Mutation of the Von Hippel-Lindau
tumour suppressor gene in capillary haemangioblastomas
of the central nervous
system. J Pathol 179: 151-156.
1932. Oda H, Nakatsuru Y, Ishikawa T
(1995). Mutations of the p53 gene and p53
protein overexpression are associated
with sarcomatoid transformation in renal
cell carcinomas. Cancer Res 55: 658-662.
1933. Oertel J, Duarte S, Ayala J, Vaux A,
Velazquez EF, Cubilla AL (2002). Squamous
cell carcinoma exclusive of the foreskin:
distinctive association with low grade variants,
multicentricity and lichen sclerosus.
Mod Pathol 15: 175A.
1934. Oesterling JE, Brendler CB, Burgers
JK, Marshall FF, Epstein JI (1990).
Advanced small cell carcinoma of the
bladder. Successful treatment with combined
radical cystoprostatectomy and
adjuvant methotrexate, vinblastine, doxorubicin,
and cisplatin chemotherapy.
Cancer 65: 1928-1936.
1935. Oesterling JE, Epstein JI, Brendler
CB (1990). Myxoid malignant fibrous histiocytoma
of the bladder. Cancer 66: 1836-
1842.
1936. Oesterling JE, Fishman EK, Goldman
SM, Marshall FF (1986). The management
of renal angiomyolipoma. J Urol 135: 1121-
1124.
1937. Oesterling JE, Jacobsen SJ, Chute
CG, Guess HA, Girman CJ, Panser LA,
Lieber MM (1993). Serum prostate-specific
antigen in a community-based population
of healthy men. Establishment of age-specific
reference ranges. JAMA 270: 860-864.
1938. Ogawa A, Sugihara S, Nakazawa Y,
Kumasaka F, Sato J, Nakanishi Y, Nakazato
Y, Honma M (1988). [A case of primary carcinoid
tumor of the testis]. Gan No Rinsho
34: 1629-1634.
1939. Ogawa O, Habuchi T, Kakehi Y,
Koshiba M, Sugiyama T, Yoshida O (1992).
Allelic losses at chromosome 17p in human
renal cell carcinoma are inversely related
to allelic losses at chromosome 3p. Cancer
Res 52: 1881-1885.
1940. Oguchi K, Takeuchi T, Kuriyama M,
Tanaka T (1988). Primary carcinoma of the
seminal vesicle (cross-imaging diagnosis).
Br J Urol 62: 383-384.
1941. Oh YL, Kim KR (2000). Micropapillary
variant of transitional cell carcinoma of the
ureter. Pathol Int 50: 52-56.
1942. Ohh M, Kaelin WGJr (1999). The von
Hippel-Lindau tumour suppressor protein:
new perspectives. Mol Med Today 5: 257-
263.
1943. Ohh M, Yauch RL, Lonergan KM,
Whaley JM, Stemmer-Rachamimov AO,
Louis DN, Gavin BJ, Kley N, Kaelin WGJr,
Iliopoulos O (1998). The von Hippel-Lindau
tumor suppressor protein is required for
proper assembly of an extracellular
fibronectin matrix. Mol Cell 1: 959-968.
1944. Ohori M, Scardino PT, Lapin SL,
Seale-Hawkins C, Link J, Wheeler TM
(1993). The mechanisms and prognostic
significance of seminal vesicle involvement
by prostate cancer. Am J Surg Pathol
17: 1252-1261.
References 335